132
Views
1
CrossRef citations to date
0
Altmetric
Review

Fractional Flow Reserve: Patient Selection and Perspectives

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 817-831 | Published online: 14 Dec 2021

References

  • Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165. doi:10.1093/eurheartj/ehy394
  • Neumann FJ, Sechtem U, Banning AP, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–477. doi:10.1093/eurheartj/ehz425
  • Kandaswamy E, Zuo L. Recent advances in treatment of coronary artery disease: role of science and technology. Int J Mol Sci. 2018;19(2):424. doi:10.3390/ijms19020424
  • Huang AL, Maggiore PL, Brown RA, et al. CT-Derived Fractional Flow Reserve (FFRCT): from gatekeeping to roadmapping. Can Assoc Radiol J. 2020;71(2):201–207. doi:10.1177/0846537119893752
  • Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. New Engl J Med. 2007;356(15):1503–1516. doi:10.1056/NEJMoa070829
  • Lukkarinen H, Hentinen M. Treatments of coronary artery disease improve quality of life in the long term. Nurs Res. 2006;55(1):26–33. doi:10.1097/00006199-200601000-00004
  • Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. New Engl J Med. 2020;382(15):1395–1407. doi:10.1056/NEJMoa1915922
  • Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP–ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. Circulation. 1999;99(21):2829–2848. doi:10.1161/01.CIR.99.21.2829
  • Mancini GBJ, Hartigan PM, Shaw LJ, et al. Predicting outcome in the COURAGE trial (Clinical outcomes utilizing revascularization and aggressive drug evaluation). JACC Cardiovasc Interv. 2014;7(2):195–201. doi:10.1016/j.jcin.2013.10.017
  • Topol EJ, Nissen SE. Our preoccupation with coronary luminology. Circulation. 1995;92(8):2333–2342. doi:10.1161/01.CIR.92.8.2333
  • Lee JM, Hwang D, Choi KH, et al. Prognostic impact of residual anatomic disease burden after functionally complete revascularization. Circ Cardiovasc Interv. 2020. doi:10.1161/CIRCINTERVENTIONS.120.009232
  • Okutucu S, Cilingiroglu M, Feldman MD. Physiologic assessment of coronary stenosis: current status and future directions. Curr Cardiol Rep. 2021;23(7):1–10. doi:10.1007/s11886-021-01521-3
  • Fournier S, Collet C, Xaplanteris P, et al. Global fractional flow reserve value predicts 5-year outcomes in patients with coronary atherosclerosis but without ischemia. J Am Heart Assoc. 2020;9(24). doi:10.1161/JAHA.120.017729
  • Achenbach S, Rudolph T, Rieber J, et al. Performing and interpreting fractional flow reserve measurements in clinical practice: an expert consensus document. Interv Cardiol Rev. 2017;12(2):97–109. doi:10.15420/icr.2017:13:2
  • Bech GJW, de Bruyne B, Pijls NHJ, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103(24):2928–2934. doi:10.1161/01.CIR.103.24.2928
  • Tonino PAL, de Bruyne B, Pijls NHJ, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. New Engl J Med. 2009;360(3):213–224. doi:10.1056/NEJMoa0807611
  • de Bruyne B, Fearon WF, Pijls NHJ, et al. Fractional flow reserve–guided PCI for stable coronary artery disease. New Engl J Med. 2014;371(13):1208–1217. doi:10.1056/nejmoa1408758
  • Xaplanteris P, Fournier S, Pijls NHJ, et al. Five-year outcomes with PCI guided by fractional flow reserve. New Engl J Med. 2018;379(3):250–259. doi:10.1056/nejmoa1803538
  • Zimmermann FM, Ferrara A, Johnson NP, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J. 2015;36(45):3182–3188. doi:10.1093/eurheartj/ehv452
  • Lindstaedt M, Yazar A, Germing A, et al. Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements. Am Heart J. 2006;152(1):156.e1–156.e9. doi:10.1016/j.ahj.2006.03.026
  • Hamilos M, Muller O, Cuisset T, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation. 2009;120(15):1505–1512. doi:10.1161/CIRCULATIONAHA.109.850073
  • Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional flow reserve–guided multivessel angioplasty in myocardial infarction. New Engl J Med. 2017;376(13):1234–1244. doi:10.1056/nejmoa1701067
  • Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575
  • Ntalianis A, Sels JW, Davidavicius G, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010;3(12):1274–1281. doi:10.1016/j.jcin.2010.08.025
  • Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65(10):963–972. doi:10.1016/j.jacc.2014.12.038
  • Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. New Engl J Med. 2013;369(12):1115–1123. doi:10.1056/nejmoa1305520
  • Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. New Engl J Med. 2019;381(15):1411–1421. doi:10.1056/nejmoa1907775
  • Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3 - PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386(9994):665–671. doi:10.1016/S0140-6736(15)60648-1
  • Kobayashi Y, Nam CW, Tonino PAL, et al. The prognostic value of residual coronary stenoses after functionally complete revascularization. J Am Coll Cardiol. 2016;67(14):1701–1711. doi:10.1016/j.jacc.2016.01.056
  • Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Utilizing post-intervention fractional flow reserve to optimize acute results and the relationship to long-term outcomes. JACC Cardiovasc Interv. 2016;9(10):1022–1031. doi:10.1016/j.jcin.2016.01.046
  • Ding D, Huang J, Westra J, et al. Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions. Eur Heart J. 2021;42(27):2695–2707. doi:10.1093/eurheartj/ehab186
  • Azzalini L, Poletti E, Demir OM, et al. Impact of post-percutaneous coronary intervention fractional flow reserve measurement on procedural management and clinical outcomes: the REPEAT-FFR study. J Interv Cardiol. 2019;31(8):229–234.
  • Collison D, Didagelos M, Aetesam-ur-Rahman M, et al. Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR). Eur Heart J. 2021:1–13. doi:10.1093/eurheartj/ehab449
  • Pargaonkar VS, Kimura T, Kameda R, et al. Invasive assessment of myocardial bridging in patients with angina and no obstructive coronary artery disease. EuroIntervention. 2021;16(13):1070–1078. doi:10.4244/EIJ-D-20-00779
  • Hakeem A, Cilingiroglu M, Leesar MA. Hemodynamic and intravascular ultrasound assessment of myocardial bridging: fractional flow reserve paradox with dobutamine versus adenosine. Catheter Cardiovasc Interv. 2010;75(2):229–236. doi:10.1002/ccd.22237
  • Tsujita K, Maehara A, Mintz GS, et al. Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery. Am J Cardiol. 2008;102(12):1608–1613. doi:10.1016/j.amjcard.2008.07.054
  • Escaned J, Cortés J, Flores A, et al. Importance of diastolic fractional flow reserve and dobutamine challenge in physiologic assessment of myocardial bridging. J Am Coll Cardiol. 2003;42(2):226–233. doi:10.1016/S0735-1097(03)00588-6
  • Jin X, Lim HS, Tahk SJ, et al. Impact of age on the functional significance of intermediate Epicardial artery disease. Circ J. 2016;80(7):1583–1589. doi:10.1253/circj.CJ-15-1402
  • Verdoia M, Gioscia R, Nardin M, et al. Impact of age on the functional evaluation of intermediate coronary stenoses with instantaneous wave-free ratio and fractional flow reserve. Angiology. 2021;72(1):62–69. doi:10.1177/0003319720947578
  • Lim HS, Tonino PAL, de Bruyne B, et al. The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional flow reserve versus angiography for multivessel evaluation) trial substudy. Int J Cardiol. 2014;177(1):66–70. doi:10.1016/j.ijcard.2014.09.010
  • McClish JC, Ragosta M, Powers ER, et al. Effect of acute myocardial infarction on the utility of fractional flow reserve for the physiologic assessment of the severity of coronary artery narrowing. Am J Cardiol. 2004;93(9):1102–1106. doi:10.1016/j.amjcard.2004.01.035
  • Biscaglia S, Guiducci V, Santarelli A, et al. Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: rationale and design of the FIRE trial. Am Heart J. 2020;229:100–109. doi:10.1016/j.ahj.2020.08.007
  • Sahinarslan A, Kocaman SA, Olgun H, et al. The reliability of fractional flow reserve measurement in patients with diabetes mellitus. Coron Artery Dis. 2009;20(5):317–321. doi:10.1097/MCA.0b013e32832c8ca3
  • Di Gioia G, Flores NS, Franco D, et al. Coronary artery bypass grafting or fractional flow reserve-guided percutaneous coronary intervention in diabetic patients with multivessel disease. Circ Cardiovasc Interv. 2020;(October):153–171. doi:10.1161/CIRCINTERVENTIONS.120.009157
  • Yanagisawa H, Chikamori T, Tanaka N, Usui Y, Takazawa K, Yamashina A. Application of pressure-derived myocardial fractional flow reserve in assessing the functional severity of coronary artery stenosis in patients with diabetes mellitus. Circ J. 2004;68:11. doi:10.1253/circj.68.993
  • Domínguez-Franco AJ, Jiménez-Navarro MF, Muñoz-García AJ, Alonso-Briales JH, Hernández-García JM, Galván EDT. Long-term prognosis in diabetic patients in whom revascularization is deferred following fractional flow reserve assessment. Revista Española de Cardiología. 2008;61(4):352–359. doi:10.1016/s1885-5857(08)60144-9
  • Lee JM, Choi KH, Koo BK, et al. Comparison of major adverse cardiac events between instantaneous wave-free ratio and fractional flow reserve-guided strategy in patients with or without type 2 diabetes: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2019;4(9):857–864. doi:10.1001/jamacardio.2019.2298
  • Leone AM, de Caterina AR, Basile E, et al. Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve. Circ Cardiovasc Interv. 2013;6(1):29–36. doi:10.1161/CIRCINTERVENTIONS.112.971101
  • Sabbah M, Nepper-Christensen L, Lønborg J, et al. Fractional flow reserve-guided PCI in patients with and without left ventricular hypertrophy: a DANAMI-3-PRIMULTI substudy. EuroIntervention. 2021;16(7):584–590. doi:10.4244/eij-d-19-00577
  • Chhatriwalla AK, Ragosta M, Powers ER, et al. High left ventricular mass index does not limit the utility of fractional flow reserve for the physiologic assessment of lesion severity. J Invasive Cardiol. 2006;18(11):544–549.
  • Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2016;18(8). doi:10.1002/ejhf.592
  • Kobayashi Y, Tonino PAL, de Bruyne B, et al. The impact of left ventricular ejection fraction on fractional flow reserve: insights from the FAME (Fractional flow reserve versus angiography for multivessel evaluation) trial. Int J Cardiol. 2016;204(2016):206–210. doi:10.1016/j.ijcard.2015.11.169
  • Di Gioia G, de Bruyne B, Pellicano M, et al. Fractional flow reserve in patients with reduced ejection fraction. Eur Heart J. 2020;41(17):1665–1672. doi:10.1093/eurheartj/ehz571
  • Toth GG, de Bruyne B, Rusinaru D, et al. Impact of right atrial pressure on fractional flow reserve measurements comparison of fractional flow reserve and myocardial fractional flow reserve in 1600 coronary stenoses. JACC Cardiovasc Interv. 2016;9(5):453–459. doi:10.1016/j.jcin.2015.11.021
  • Mejia-Renteria H, Nombela-Franco L, Paradis JM, et al. Angiography-based quantitative flow ratio versus fractional flow reserve in patients with coronary artery disease and severe aortic stenosis. EuroIntervention. 2021;16(4):E285–E292. doi:10.4244/eij-d-19-01001
  • Di Gioia G, Pellicano M, Toth GG, et al. Fractional flow reserve-guided revascularization in patients with aortic stenosis. Am J Cardiol. 2016;117(9):1511–1515. doi:10.1016/j.amjcard.2016.02.023
  • Pesarini G, Scarsini R, Zivelonghi C, et al. Functional assessment of coronary artery disease in patients undergoing transcatheter aortic valve implantation: influence of pressure overload on the evaluation of lesions severity. Circ Cardiovasc Interv. 2016;9(11):1–10. doi:10.1161/CIRCINTERVENTIONS.116.004088
  • Vendrik J, Ahmad Y, Eftekhari A, et al. Long-term effects of transcatheter aortic valve implantation on coronary hemodynamics in patients with concomitant coronary artery disease and severe aortic stenosis. J Am Heart Assoc. 2020;9(5). doi:10.1161/JAHA.119.015133
  • Changal K, Patel M, Salman FNU, Nazir S, Gupta R. Meta-analysis comparing angiography-guided versus ffr-guided coronary artery bypass grafting. Am J Cardiol. 2020;135:184–185. doi:10.1016/j.amjcard.2020.09.002
  • Timbadia D, Ler A, Sazzad F, Alexiou C, Kofidis T. FFR-guided versus coronary angiogram-guided CABG: a review and meta-analysis of prospective randomized controlled trials. J Card Surg. 2020;35(10):2785–2793. doi:10.1111/jocs.14880
  • Bruno F, D’Ascenzo F, Marengo G, et al. Fractional flow reserve guided versus angiographic guided surgical revascularization: a meta-analysis. Catheter Cardiovasc Interv. 2020. doi:10.1002/ccd.29427
  • Fournier S, Toth GG, de Bruyne B, et al. Six-year follow-up of fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circ Cardiovasc Interv. 2018;11(6):1–7. doi:10.1161/CIRCINTERVENTIONS.117.006368
  • Wermers J, Torguson R. FUTURE trial does not indicate advantage for FFR over angiography alone in multivessel disease patients. Available from: https://www.crtonline.org/news-detail/future-trial-does-not-indicate-advantage-ffr-over-. Accessed November 30, 2021.
  • Neale T. FUTURE results confirm more deaths with FFR-guided treatment choice. Available from: https://www.tctmd.com/news/future-results-confirm-more-deaths-ffr-guided-treatment-choice. Accessed November 30, 2021.
  • Koo BK, Park KW, Kang HJ, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J. 2008;29(6):726–732. doi:10.1093/eurheartj/ehn045
  • Koo BK, Waseda K, Kang HJ, et al. Anatomic and functional evaluation of bifurcation lesions undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2010;3(2):113–119. doi:10.1161/CIRCINTERVENTIONS.109.887406
  • Ahn JM, Lee JY, Kang SJ, et al. Functional assessment of jailed side branches in coronary bifurcation lesions using fractional flow reserve. JACC Cardiovasc Interv. 2012;5(2):155–161. doi:10.1016/j.jcin.2011.10.015
  • Koo BK, Kang HJ, Youn TJ, et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol. 2005;46(4):633–637. doi:10.1016/j.jacc.2005.04.054
  • Koo BK. Physiologic evaluation of bifurcation lesions using fractional flow reserve. J Interv Cardiol. 2009;22(2):110–113. doi:10.1111/j.1540-8183.2009.00437.x
  • Kang SJ, Ahn JM, Kim WJ, et al. Functional and morphological assessment of side branch after left main coronary artery bifurcation stenting with cross-over technique. Catheter Cardiovasc Interv. 2014;83(4):545–552. doi:10.1002/ccd.25057
  • Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391:10115. doi:10.1016/S0140-6736(17)32714-9
  • Soares A, Brown DL. The fallacies of fractional flow reserve. Int J Cardiol. 2020;302(2020):34–35. doi:10.1016/j.ijcard.2019.12.040
  • Demir OM, Schrieken C, Curio J, Rahman H. Behavioural determinants impacting the adoption rate of coronary physiology. Int J Cardiol. 2021;330:12–14. doi:10.1016/j.ijcard.2021.02.008
  • de Waard GA, Hollander MR, Teunissen PFA, et al. Changes in coronary blood flow after acute myocardial infarction: insights from a patient study and an experimental porcine model. JACC Cardiovasc Interv. 2016;9(6):602–613. doi:10.1016/j.jcin.2016.01.001
  • Thim T, Götberg M, Fröbert O, et al. Agreement between nonculprit stenosis follow-up iFR and FFR after STEMI (iSTEMI substudy). BMC Res Notes. 2020;13(1):1–3. doi:10.1186/s13104-020-05252-6
  • Li Y, Shi Z, Cai Y, et al. Impact of coronary tortuosity on coronary pressure: numerical simulation study. PLoS One. 2012;7(8):3–8. doi:10.1371/journal.pone.0042558
  • Li Y, Zhang X, Dai Q, Ma G. Coronary flow reserve and microcirculatory resistance in patients with coronary tortuosity and without atherosclerosis. J Int Med Res. 2020;48(9). doi:10.1177/0300060520955060
  • Xie X, Wang Y, Zhu H, Zhou H, Zhou J. Impact of coronary tortuosity on coronary blood supply: a Patient-Specific Study. PLoS One. 2013;8(5):1–10. doi:10.1371/journal.pone.0064564
  • Nederland Z. Farmacotherapeutisch Kompas: adenosine. Available from: https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/a/adenosine#contra-indicaties. Accessed November 30, 2021.
  • Sen S, Escaned J, Malik IS, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine vasodilator independent stenosis evaluation) study. J Am Coll Cardiol. 2012;59(15):1392–1402. doi:10.1016/j.jacc.2011.11.003
  • Svanerud J, Ahn JM, Jeremias A, et al. Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. EuroIntervention. 2018;14(7):806–814. doi:10.4244/EIJ-D-18-00342
  • Johnson NP, Li W, Chen X, et al. Diastolic pressure ratio: new approach and validation vs. the instantaneous wave-free ratio. Eur Heart J. 2019;40(31):2585–2594. doi:10.1093/eurheartj/ehz230
  • Van’t Veer M, Pijls NHJ, Hennigan B, et al. Comparison of different diastolic resting indexes to iFR: are they all equal? J Am Coll Cardiol. 2017;70(25):3088–3096. doi:10.1016/j.jacc.2017.10.066
  • Davies JE, Sen S, Dehbi HM, et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. New Engl J Med. 2017;376(19):1824–1834. doi:10.1056/NEJMoa1700445
  • Sen S, Escaned J, Malik IS, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave–intensity analysis. J Am Coll Cardiol. 2012;59(15):1392–1402. doi:10.1016/j.jacc.2011.11.003
  • de Waard G, Di Mario C, Lerman A, Serruys P, van Royen N. Instantaneous wave-free ratio to guide coronary revascularisation: physiological framework, validation and differences from fractional flow reserve. EuroIntervention. 2017;13(4):450–458. doi:10.4244/EIJ-D-16-00456
  • Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. New Engl J Med. 2017;376(19):1813–1823. doi:10.1056/NEJMoa1616540
  • Koo BK, Erglis A, Doh JH, et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. J Am Coll Cardiol. 2011;58(19):1989–1997. doi:10.1016/j.jacc.2011.06.066
  • Nakazato R, Park HB, Berman DS, et al. Noninvasive fractional flow reserve derived from computed tomography angiography for coronary lesions of intermediate stenosis severity. Circ Cardiovasc Imaging. 2013;6(6):881–889. doi:10.1161/CIRCIMAGING.113.000297
  • Gaur S, Achenbach S, Leipsic J, et al. Rationale and design of the HeartFlowNXT (HeartFlow analysis of coronary blood flow using CT angiography: neXt sTeps) study. J Cardiovasc Comput Tomogr. 2013;7(5):279–288. doi:10.1016/j.jcct.2013.09.003
  • van Hamersvelt RW, Voskuil M, de Jong PA, Willemink MJ, Išgum I, Leiner T. Diagnostic performance of on-site coronary CT angiography–derived fractional flow reserve based on patient-specific lumped parameter models. Radiology. 2019;1(4):e190036. doi:10.1148/ryct.2019190036
  • Donnelly PM, Kolossváry M, Karády J, et al. Experience with an on-site coronary computed tomography-derived fractional flow reserve algorithm for the assessment of intermediate coronary stenoses. Am J Cardiol. 2018;121(1):9–13. doi:10.1016/j.amjcard.2017.09.018
  • Coenen A, Lubbers MM, Kurata A, et al. Fractional flow reserve computed from noninvasive CT angiography data: diagnostic performance of an on-site clinician-operated computational fluid dynamics algorithm. Radiology. 2015;274(3):674–683. doi:10.1148/radiol.14140992
  • Ihdayhid AR, Sakaguchi T, Linde JJ, et al. Performance of computed tomography-derived fractional flow reserve using reduced-order modelling and static computed tomography stress myocardial perfusion imaging for detection of haemodynamically significant coronary stenosis. Eur Heart J Cardiovasc Imaging. 2018;19(11):1234–1243. doi:10.1093/ehjci/jey114
  • Ko BS, Cameron JD, Munnur RK, et al. Noninvasive CT-derived FFR based on structural and fluid analysis: a comparison with Invasive FFR for detection of functionally significant stenosis. JACC Cardiovasc Imaging. 2017;10(6):663–673. doi:10.1016/j.jcmg.2016.07.005
  • Renker M, Schoepf UJ, Wang R, et al. Comparison of diagnostic value of a novel noninvasive coronary computed tomography angiography method versus standard coronary angiography for assessing fractional flow reserve. Am J Cardiol. 2014;114(9):1303–1308. doi:10.1016/j.amjcard.2014.07.064
  • Yang L, Xu L, He J, et al. Diagnostic performance of a fast non-invasive fractional flow reserve derived from coronary CT angiography: an initial validation study. Clin Radiol. 2019;74(12):973.e1–973.e6. doi:10.1016/j.crad.2019.08.007
  • Peper J, Schaap J, Kelder JC, et al. Added value of computed tomography fractional flow reserve in the diagnosis of coronary artery disease. Sci Rep. 2021;11(1):1–9. doi:10.1038/s41598-021-86245-8
  • Celeng C, Leiner T, Maurovich-Horvat P, et al. Anatomical and functional computed tomography for diagnosing hemodynamically significant coronary artery disease: a meta-analysis. JACC Cardiovasc Imaging. 2019;12(7):1316–1325. doi:10.1016/j.jcmg.2018.07.022
  • Tu S, Barbato E, Köszegi Z, et al. Fractional flow reserve calculation from 3-dimensional quantitative coronary angiography and TIMI frame count. JACC Cardiovasc Interv. 2014;7(7):768–777. doi:10.1016/j.jcin.2014.03.004
  • Collet C, Onuma Y, Sonck J, et al. Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis. Eur Heart J. 2018;39(35):3314–3321. doi:10.1093/eurheartj/ehy445
  • Tu S, Westra J, Yang J, et al. Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography: the international multicenter FAVOR Pilot Study. JACC Cardiovasc Interv. 2016;9(19):2024–2035. doi:10.1016/j.jcin.2016.07.013
  • Xu B, Tu S, Qiao S, et al. Diagnostic accuracy of angiography-based quantitative flow ratio measurements for online assessment of coronary stenosis. J Am Coll Cardiol. 2017;70(25):3077–3087. doi:10.1016/j.jacc.2017.10.035
  • Westra J, Andersen BK, Campo G, et al. Diagnostic performance of in‐procedure angiography‐derived quantitative flow reserve compared to pressure‐derived fractional flow reserve: the FAVOR II Europe‐Japan Study. J Am Heart Assoc. 2018;7(14). doi:10.1161/JAHA.118.009603
  • Westra J, Tu S, Winther S, et al. Evaluation of coronary artery stenosis by quantitative flow ratio during invasive coronary angiography. Circ Cardiovasc Imaging. 2018;11(3). doi:10.1161/CIRCIMAGING.117.007107
  • Masdjedi K, van Zandvoort LJC, Balbi MM, et al. Validation of a three-dimensional quantitative coronary angiography-based software to calculate fractional flow reserve: the FAST study. EuroIntervention. 2021;16(7):591–599. doi:10.4244/eij-d-19-00466
  • Seike F, Uetani T, Nishimura K, et al. Correlation between quantitative angiography–derived translesional pressure and fractional flow reserve. Am J Cardiol. 2016;118(8):1158–1163. doi:10.1016/j.amjcard.2016.07.026
  • Papafaklis MI, Muramatsu T, Ishibashi Y, et al. Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire - fractional flow reserve. EuroIntervention. 2014;10(5):574–583. doi:10.4244/EIJY14M07_01
  • Morris PD, Ryan D, Morton AC, et al. Virtual fractional flow reserve from coronary angiography: modeling the significance of coronary lesions. Results from the VIRTU-1 (VIRTUal fractional flow reserve from coronary angiography) study. JACC Cardiovasc Interv. 2013;6(2):149–157. doi:10.1016/j.jcin.2012.08.024
  • Tröbs M, Achenbach S, Röther J, et al. Comparison of fractional flow reserve based on computational fluid dynamics modeling using coronary angiographic vessel morphology versus invasively measured fractional flow reserve. Am J Cardiol. 2016;117(1):29–35. doi:10.1016/j.amjcard.2015.10.008
  • Levine GN, Bates ER, Blankenship JC, et al. ACCF/AHA/SCAI guideline for percutaneous coronary intervention a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):574–651. doi:10.1161/CIR.0b013e31823ba622
  • Lotfi A, Jeremias A, Fearon WF, et al. Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: a consensus statement of the society of cardiovascular angiography and interventions. Catheter Cardiovasc Interv. 2014;83(4):509–518. doi:10.1002/ccd.25222